{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "02", "@year": "2024", "@timestamp": "2024-11-02T01:54:03.000003-04:00", "@month": "11"}, "ait:date-sort": {"@day": "01", "@year": "2014", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "United States", "address-part": "101 Manning Drive", "postal-code": "27514", "@afid": "60002968", "@country": "usa", "city": "Chapel Hill", "organization": [{"$": "Department of Pathology and Laboratory Medicine"}, {"$": "University of North Carolina"}, {"$": "UNC Hospitals"}], "affiliation-id": [{"@afid": "60002968"}, {"@afid": "60025111"}, {"@afid": "60020469"}], "state": "NC"}, "author": [{"ce:given-name": "Phandee", "preferred-name": {"ce:given-name": "Phandee", "ce:initials": "P.", "ce:surname": "Watanaboonyongcharoen", "ce:indexed-name": "Watanaboonyongcharoen P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Watanaboonyongcharoen", "@auid": "54780784500", "ce:indexed-name": "Watanaboonyongcharoen P."}, {"ce:given-name": "Herbert C.", "preferred-name": {"ce:given-name": "Herbert C.", "ce:initials": "H.C.", "ce:surname": "Whinna", "ce:indexed-name": "Whinna H.C."}, "@seq": "2", "ce:initials": "H.C.", "@_fa": "true", "@type": "auth", "ce:surname": "Whinna", "@auid": "6601960784", "ce:indexed-name": "Whinna H.C."}, {"ce:given-name": "Yara A.", "preferred-name": {"ce:given-name": "Yara A.", "ce:initials": "Y.A.", "ce:surname": "Park", "ce:indexed-name": "Park Y.A."}, "@seq": "3", "ce:initials": "Y.A.", "@_fa": "true", "@type": "auth", "ce:surname": "Park", "@auid": "16417692500", "ce:indexed-name": "Park Y.A."}]}, {"affiliation": {"country": "Thailand", "@afid": "60022183", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Transfusion Medicine Unit"}, {"$": "King Chulalongkorn Memorial Hospital"}], "affiliation-id": {"@afid": "60022183", "@dptid": "112227767"}, "@dptid": "112227767"}, "author": [{"ce:given-name": "Phandee", "preferred-name": {"ce:given-name": "Phandee", "ce:initials": "P.", "ce:surname": "Watanaboonyongcharoen", "ce:indexed-name": "Watanaboonyongcharoen P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Watanaboonyongcharoen", "@auid": "54780784500", "ce:indexed-name": "Watanaboonyongcharoen P."}]}], "citation-title": "Interferon-\u03b1 is not elevated in idiopathic thrombotic thrombocytopenic purpura patients", "abstracts": "\u00a9 2014 Wiley Periodicals, Inc.Idiopathic thrombotic thrombocytopenic purpura (TTP) patients have ADAMTS13 deficiency, which is usually caused by ADAMTS13 autoantibodies. However, the triggering factors for the autoantibody production remain unclear. Interferon-\u03b1 (IFN-a) is a cytokine involved with many autoimmune processes such as inducing the activation of peripheral dendritic cells and stimulating T cells and B cells. It also plays an important role in some autoimmune diseases. Elevated IFN-\u03b1 levels have been observed in some TTP patients and previous case reports have shown the occurrence of TTP after IFN-\u03b1 treatment. Thus, we hypothesized that high levels of IFN-\u03b1 would correlate with presence of ADAMTS13 autoantibodies. However, we did not observe elevated IFN-\u03b1 levels in 36 TTP patients (mean 5.29 pg/ml, standard deviation (SD) 26.56 pg/ml) compared to healthy controls (mean 0 pg/ml, SD 0 pg/ml), P50.59. IFN-\u03b1 levels of most patients (94%) were undetectable. Only two patients had increased IFN-\u03b1 levels and ADAMTS13 autoantibodies were detected in these two patients. Interestingly, both the patients had an underlying autoimmune disease. Although there have been cases of secondary TTP following IFN-\u03b1 treatment, no evidence supports a role of IFN-\u03b1 in the development of idiopathic TTP in our patient population.", "correspondence": {"affiliation": {"country": "United States", "address-part": "101 Manning Drive", "postal-code": "27514", "@country": "usa", "city": "Chapel Hill", "organization": [{"$": "Department of Pathology and Laboratory Medicine"}, {"$": "University of North Carolina"}, {"$": "UNC Hospitals"}], "state": "NC"}, "person": {"ce:given-name": "Yara A.", "ce:initials": "Y.A.", "ce:surname": "Park", "ce:indexed-name": "Park Y.A."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "ADAMTS13 autoantibodies", "@xml:lang": "eng"}, {"$": "Interferon-\u03b1", "@xml:lang": "eng"}, {"$": "Thrombotic thrombocytopenic purpura", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1101", "@type": "email"}}, "translated-sourcetitle": {"$": "Journal of Clinical Apheresis", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "29", "@issue": "6"}, "pagerange": {"@first": "336", "@last": "338"}}, "@type": "j", "sourcetitle": "Journal of Clinical Apheresis", "publicationdate": {"month": "12", "year": "2014", "date-text": {"@xfab-added": "true", "$": "1 December 2014"}, "day": "01"}, "codencode": "JCAPE", "sourcetitle-abbrev": "J. Clin. Apheresis", "@country": "usa", "issn": [{"$": "10981101", "@type": "electronic"}, {"$": "07332459", "@type": "print"}], "publicationyear": {"@first": "2014"}, "publisher": {"publishername": "Wiley-Liss Inc."}, "@srcid": "25998"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "25", "classification-description": "Hematology"}, {"classification-code": "26", "classification-description": "Immunology, Serology and Transplantation"}, {"classification-code": "6", "classification-description": "Internal Medicine"}]}, {"@type": "ASJC", "classification": "2720"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": {"cas-registry-number": "334869-10-2", "chemical-name": "von Willebrand factor cleaving proteinase"}}, {"@source": "nlm", "chemical": [{"chemical-name": "ADAM Proteins"}, {"chemical-name": "ADAMTS13 protein, human"}, {"chemical-name": "Autoantibodies"}, {"chemical-name": "Interferon-alpha"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2021 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "external-source": "MEDLINE", "dbcollection": [{"$": "EMBASE"}, {"$": "MEDL"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "27", "@year": "2021", "@timestamp": "BST 09:13:38", "@month": "09"}}, "itemidlist": {"itemid": [{"$": "53118527", "@idtype": "PUI"}, {"$": "625111466", "@idtype": "CAR-ID"}, {"$": "2014712801", "@idtype": "EMBASE"}, {"$": "24764259", "@idtype": "MEDL"}, {"$": "20213532468", "@idtype": "REAXYSCAR"}, {"$": "20143072792", "@idtype": "SCOPUS"}, {"$": "84918827703", "@idtype": "SCP"}, {"$": "84918827703", "@idtype": "SGR"}, {"$": "605612122", "@idtype": "PUIsecondary"}], "ce:doi": "10.1002/jca.21322"}}, "tail": {"bibliography": {"@refcount": "11", "reference": [{"ref-fulltext": "Sadler JE, Moake JL, Miyata T, George JN,. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004; 407-423.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Recent advances in thrombotic thrombocytopenic purpura"}, "refd-itemidlist": {"itemid": {"$": "20444446312", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "407", "@last": "423"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.E.", "@_fa": "true", "ce:surname": "Sadler", "ce:indexed-name": "Sadler J.E."}, {"@seq": "2", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Moake", "ce:indexed-name": "Moake J.L."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Miyata", "ce:indexed-name": "Miyata T."}, {"@seq": "4", "ce:initials": "J.N.", "@_fa": "true", "ce:surname": "George", "ce:indexed-name": "George J.N."}]}, "ref-sourcetitle": "Hematology Am Soc Hematol Educ Program"}}, {"ref-fulltext": "Ronnblom L, Pascual V,. The innate immune system in SLE: type I interferons and dendritic cells. Lupus 2008; 17: 394-399.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "The innate immune system in SLE: Type i interferons and dendritic cells"}, "refd-itemidlist": {"itemid": {"$": "44849085476", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "394", "@last": "399"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Ronnblom", "ce:indexed-name": "Ronnblom L."}, {"@seq": "2", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Pascual", "ce:indexed-name": "Pascual V."}]}, "ref-sourcetitle": "Lupus"}}, {"ref-fulltext": "Banchereau J, Pascual V, Palucka AK,. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004; 20: 539-550.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Autoimmunity through cytokine-induced dendritic cell activation"}, "refd-itemidlist": {"itemid": {"$": "2442494120", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "539", "@last": "550"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Banchereau", "ce:indexed-name": "Banchereau J."}, {"@seq": "2", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Pascual", "ce:indexed-name": "Pascual V."}, {"@seq": "3", "ce:initials": "A.K.", "@_fa": "true", "ce:surname": "Palucka", "ce:indexed-name": "Palucka A.K."}]}, "ref-sourcetitle": "Immunity"}}, {"ref-fulltext": "Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, Ronnblom L,. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000; 9: 664-671.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Activation of type i interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies"}, "refd-itemidlist": {"itemid": {"$": "0034533825", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "664", "@last": "671"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Bengtsson", "ce:indexed-name": "Bengtsson A.A."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Sturfelt", "ce:indexed-name": "Sturfelt G."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Truedsson", "ce:indexed-name": "Truedsson L."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Blomberg", "ce:indexed-name": "Blomberg J."}, {"@seq": "5", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Alm", "ce:indexed-name": "Alm G."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Vallin", "ce:indexed-name": "Vallin H."}, {"@seq": "7", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Ronnblom", "ce:indexed-name": "Ronnblom L."}]}, "ref-sourcetitle": "Lupus"}}, {"ref-fulltext": "Petri M, Wallace DJ, Spindler A, Chindalore V, Kalunian K, Mysler E, Neuwelt CM, Robbie G, White WI, Higgs BW, Yao Y, Wang L, Ethgen D, Greth W,. Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum 2013; 65: 1011-1021.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: A phase i randomized, controlled, dose-escalation study"}, "refd-itemidlist": {"itemid": {"$": "84875697484", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "65"}, "pagerange": {"@first": "1011", "@last": "1021"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Petri", "ce:indexed-name": "Petri M."}, {"@seq": "2", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Wallace", "ce:indexed-name": "Wallace D.J."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Spindler", "ce:indexed-name": "Spindler A."}, {"@seq": "4", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Chindalore", "ce:indexed-name": "Chindalore V."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Kalunian", "ce:indexed-name": "Kalunian K."}, {"@seq": "6", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Mysler", "ce:indexed-name": "Mysler E."}, {"@seq": "7", "ce:initials": "C.M.", "@_fa": "true", "ce:surname": "Neuwelt", "ce:indexed-name": "Neuwelt C.M."}, {"@seq": "8", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Robbie", "ce:indexed-name": "Robbie G."}, {"@seq": "9", "ce:initials": "W.I.", "@_fa": "true", "ce:surname": "White", "ce:indexed-name": "White W.I."}, {"@seq": "10", "ce:initials": "B.W.", "@_fa": "true", "ce:surname": "Higgs", "ce:indexed-name": "Higgs B.W."}, {"@seq": "11", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yao", "ce:indexed-name": "Yao Y."}, {"@seq": "12", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang L."}, {"@seq": "13", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Ethgen", "ce:indexed-name": "Ethgen D."}, {"@seq": "14", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Greth", "ce:indexed-name": "Greth W."}]}, "ref-sourcetitle": "Arthritis Rheum"}}, {"ref-fulltext": "Zuber J, Martinez F, Droz D, Oksenhendler E, Legendre C,. Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature. Medicine (Baltimore) 2002; 81: 321-331.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Alpha-interferon-associated thrombotic microangiopathy: A clinicopathologic study of 8 patients and review of the literature"}, "refd-itemidlist": {"itemid": {"$": "0036311308", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "81"}, "pagerange": {"@first": "321", "@last": "331"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Zuber", "ce:indexed-name": "Zuber J."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Martinez", "ce:indexed-name": "Martinez F."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Droz", "ce:indexed-name": "Droz D."}, {"@seq": "4", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Oksenhendler", "ce:indexed-name": "Oksenhendler E."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Legendre", "ce:indexed-name": "Legendre C."}]}, "ref-sourcetitle": "Medicine (Baltimore)"}}, {"ref-fulltext": "Deutsch M, Manesis EK, Hadziyannis E, Vassilopoulos D, Archimandritis AJ,. Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b. Scand J gastroenterol 2007; 42: 408-409.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b"}, "refd-itemidlist": {"itemid": {"$": "33847206025", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "42"}, "pagerange": {"@first": "408", "@last": "409"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Deutsch", "ce:indexed-name": "Deutsch M."}, {"@seq": "2", "ce:initials": "E.K.", "@_fa": "true", "ce:surname": "Manesis", "ce:indexed-name": "Manesis E.K."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Hadziyannis", "ce:indexed-name": "Hadziyannis E."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Vassilopoulos", "ce:indexed-name": "Vassilopoulos D."}, {"@seq": "5", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Archimandritis", "ce:indexed-name": "Archimandritis A.J."}]}, "ref-sourcetitle": "Scand J Gastroenterol"}}, {"ref-fulltext": "Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S,. Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 1992; 40: 167-170.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Plasma cytokine levels in thrombotic thrombocytopenic purpura"}, "refd-itemidlist": {"itemid": {"$": "0026638736", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "167", "@last": "170"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Wada", "ce:indexed-name": "Wada H."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Kaneko", "ce:indexed-name": "Kaneko T."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Ohiwa", "ce:indexed-name": "Ohiwa M."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Tanigawa", "ce:indexed-name": "Tanigawa M."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Tamaki", "ce:indexed-name": "Tamaki S."}, {"@seq": "6", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Minami", "ce:indexed-name": "Minami N."}, {"@seq": "7", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Takahashi", "ce:indexed-name": "Takahashi H."}, {"@seq": "8", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Deguchi", "ce:indexed-name": "Deguchi K."}, {"@seq": "9", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Nakano", "ce:indexed-name": "Nakano T."}, {"@seq": "10", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Shirakawa", "ce:indexed-name": "Shirakawa S."}]}, "ref-sourcetitle": "Am J Hematol"}}, {"ref-fulltext": "Park YA, Schultz EF, Hay SN, Brecher ME,. Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol 2011; 135: 85-88.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Thrombotic thrombocytopenic purpura and urinary tract infections: Is there a connection?"}, "refd-itemidlist": {"itemid": {"$": "79251500334", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "135"}, "pagerange": {"@first": "85", "@last": "88"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.A.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park Y.A."}, {"@seq": "2", "ce:initials": "E.F.", "@_fa": "true", "ce:surname": "Schultz", "ce:indexed-name": "Schultz E.F."}, {"@seq": "3", "ce:initials": "S.N.", "@_fa": "true", "ce:surname": "Hay", "ce:indexed-name": "Hay S.N."}, {"@seq": "4", "ce:initials": "M.E.", "@_fa": "true", "ce:surname": "Brecher", "ce:indexed-name": "Brecher M.E."}]}, "ref-sourcetitle": "Am J Clin Pathol"}}, {"ref-fulltext": "Sarode R, Bandarenko N, Brecher ME, Kiss JE, Marques MB, Szczepiorkowski ZM, Winters JL,. Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apher, DOI: 10.1002/jca.21302.", "@id": "10", "ref-info": {"ref-title": {"ref-titletext": "Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research"}, "refd-itemidlist": {"itemid": {"$": "84902529329", "@idtype": "SGR"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Sarode", "ce:indexed-name": "Sarode R."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Bandarenko", "ce:indexed-name": "Bandarenko N."}, {"@seq": "3", "ce:initials": "M.E.", "@_fa": "true", "ce:surname": "Brecher", "ce:indexed-name": "Brecher M.E."}, {"@seq": "4", "ce:initials": "J.E.", "@_fa": "true", "ce:surname": "Kiss", "ce:indexed-name": "Kiss J.E."}, {"@seq": "5", "ce:initials": "M.B.", "@_fa": "true", "ce:surname": "Marques", "ce:indexed-name": "Marques M.B."}, {"@seq": "6", "ce:initials": "Z.M.", "@_fa": "true", "ce:surname": "Szczepiorkowski", "ce:indexed-name": "Szczepiorkowski Z.M."}, {"@seq": "7", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Winters", "ce:indexed-name": "Winters J.L."}]}, "ref-sourcetitle": "J Clin Apher"}}, {"ref-fulltext": "Bocci V,. Roles of interferon produced in physiological conditions. A speculative review. Immunology 1988; 64: 1-9.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "ref-title": {"ref-titletext": "Roles of interferon produced in physiological conditions. A speculative review"}, "refd-itemidlist": {"itemid": {"$": "0023895986", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "64"}, "pagerange": {"@first": "1", "@last": "9"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Bocci", "ce:indexed-name": "Bocci V."}]}, "ref-sourcetitle": "Immunology"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}, {"affiliation-city": "Chapel Hill", "@id": "60002968", "affilname": "UNC Health", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002968", "affiliation-country": "United States"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84918827703", "dc:description": "Idiopathic thrombotic thrombocytopenic purpura (TTP) patients have ADAMTS13 deficiency, which is usually caused by ADAMTS13 autoantibodies. However, the triggering factors for the autoantibody production remain unclear. Interferon-\u03b1 (IFN-a) is a cytokine involved with many autoimmune processes such as inducing the activation of peripheral dendritic cells and stimulating T cells and B cells. It also plays an important role in some autoimmune diseases. Elevated IFN-\u03b1 levels have been observed in some TTP patients and previous case reports have shown the occurrence of TTP after IFN-\u03b1 treatment. Thus, we hypothesized that high levels of IFN-\u03b1 would correlate with presence of ADAMTS13 autoantibodies. However, we did not observe elevated IFN-\u03b1 levels in 36 TTP patients (mean 5.29 pg/ml, standard deviation (SD) 26.56 pg/ml) compared to healthy controls (mean 0 pg/ml, SD 0 pg/ml), P50.59. IFN-\u03b1 levels of most patients (94%) were undetectable. Only two patients had increased IFN-\u03b1 levels and ADAMTS13 autoantibodies were detected in these two patients. Interestingly, both the patients had an underlying autoimmune disease. Although there have been cases of secondary TTP following IFN-\u03b1 treatment, no evidence supports a role of IFN-\u03b1 in the development of idiopathic TTP in our patient population.", "pubmed-id": "24764259", "prism:coverDate": "2014-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84918827703", "dc:creator": {"author": [{"ce:given-name": "Phandee", "preferred-name": {"ce:given-name": "Phandee", "ce:initials": "P.", "ce:surname": "Watanaboonyongcharoen", "ce:indexed-name": "Watanaboonyongcharoen P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": [{"@id": "60002968", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002968"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:surname": "Watanaboonyongcharoen", "@auid": "54780784500", "author-url": "https://api.elsevier.com/content/author/author_id/54780784500", "ce:indexed-name": "Watanaboonyongcharoen P."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84918827703"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84918827703&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84918827703&origin=inward"}], "source-id": "25998", "citedby-count": "0", "prism:volume": "29", "subtype": "ar", "dc:title": "Interferon-\u03b1 is not elevated in idiopathic thrombotic thrombocytopenic purpura patients", "openaccess": "0", "prism:issn": "10981101 07332459", "publishercopyright": "\u00a9 2014 Wiley Periodicals, Inc.", "prism:issueIdentifier": "6", "subtypeDescription": "Article", "prism:publicationName": "Journal of Clinical Apheresis", "prism:pageRange": "336-338", "prism:endingPage": "338", "openaccessFlag": "false", "prism:doi": "10.1002/jca.21322", "prism:startingPage": "336", "dc:identifier": "SCOPUS_ID:84918827703", "dc:publisher": "Wiley-Liss Inc."}, "idxterms": {"mainterm": [{"$": "ADAM Proteins", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Autoantibodies", "@weight": "b", "@candidate": "n"}, {"$": "Autoimmune Diseases", "@weight": "b", "@candidate": "n"}, {"$": "Blood Component Removal", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Interferon-alpha", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Purpura, Thrombotic Thrombocytopenic", "@weight": "b", "@candidate": "n"}, {"$": "Thrombotic Microangiopathies", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "ADAMTS13 autoantibodies"}, {"@_fa": "true", "$": "Interferon-\u03b1"}, {"@_fa": "true", "$": "Thrombotic thrombocytopenic purpura"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Hematology", "@code": "2720", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Phandee", "preferred-name": {"ce:given-name": "Phandee", "ce:initials": "P.", "ce:surname": "Watanaboonyongcharoen", "ce:indexed-name": "Watanaboonyongcharoen P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": [{"@id": "60002968", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002968"}, {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}], "ce:surname": "Watanaboonyongcharoen", "@auid": "54780784500", "author-url": "https://api.elsevier.com/content/author/author_id/54780784500", "ce:indexed-name": "Watanaboonyongcharoen P."}, {"ce:given-name": "Herbert C.", "preferred-name": {"ce:given-name": "Herbert C.", "ce:initials": "H.C.", "ce:surname": "Whinna", "ce:indexed-name": "Whinna H.C."}, "@seq": "2", "ce:initials": "H.C.", "@_fa": "true", "affiliation": {"@id": "60002968", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002968"}, "ce:surname": "Whinna", "@auid": "6601960784", "author-url": "https://api.elsevier.com/content/author/author_id/6601960784", "ce:indexed-name": "Whinna H.C."}, {"ce:given-name": "Yara A.", "preferred-name": {"ce:given-name": "Yara A.", "ce:initials": "Y.A.", "ce:surname": "Park", "ce:indexed-name": "Park Y.A."}, "@seq": "3", "ce:initials": "Y.A.", "@_fa": "true", "affiliation": {"@id": "60002968", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002968"}, "ce:surname": "Park", "@auid": "16417692500", "author-url": "https://api.elsevier.com/content/author/author_id/16417692500", "ce:indexed-name": "Park Y.A."}]}}}